Please ensure Javascript is enabled for purposes of website accessibility

Civica

AstraZeneca CEO Pascal Soriot and then-Gov. Glenn Youngkin announced the company’s planned $4.5 billion plants in October 2025. Photo by Kaitlyn DeHarde, Office of Gov. Glenn Youngkin
Mar 2, 2026

Preparation, pandemic helped Virginia land Big Pharma deals

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.

Default Alt Text
Oct 17, 2025

Civica to start selling long-acting insulin in January 2026

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.